Categories
rss rss-es rss-pt

FDA In Brief: FDA Alerts Patients and Health Care Providers About Possible Problems with Mammograms Performed at Capitol Radiology LLC

Murilo Freitas - 16:19, 19 de mayo de 2021413

FDA In Brief: FDA Alerts Patients and Health Care Providers About Possible Problems with Mammograms Performed at Capitol Radiology LLC
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-alerts-patients-and-health-care-providers-about-possible-problems-mammograms-performed

 
Categories
rss rss-es rss-pt

FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available

Murilo Freitas - 21:45, 18 de mayo de 2021492

FDA In Brief: FDA Authorizes Longer Time for Refrigerator Storage of Thawed Pfizer-BioNTech COVID-19 Vaccine Prior to Dilution, Making Vaccine More Widely Available
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-authorizes-longer-time-refrigerator-storage-thawed-pfizer-biontech-covid-19-vaccine

 
Categories
rss rss-es rss-pt

Permanece porcentaje de mortalidad COVID-19: 90% de los decesos se dan por la enfermedad

Murilo Freitas - 17:09, 18 de mayo de 2021481

Permanece porcentaje de mortalidad COVID-19: 90% de los decesos se dan por la enfermedad

Permanece porcentaje de mortalidad COVID-19: 90% de los decesos se dan por la enfermedadMiércoles 19 de mayo del 2021. La Comisión de Mortalidad Covid-19, que examina cada uno de los decesos que se registran relacionados...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2100-permanece-porcentaje-de-mortalidad-covid-19-90-de-los-decesos-se-dan-por-la-enfermedad

 
Categories
rss rss-es rss-pt

FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes

Murilo Freitas - 16:51, 18 de mayo de 2021373

FDA In Brief: FDA Issues Draft Guidance on Early Clinical Studies for Certain Medical Devices to Improve Glycemic Control for Type 2 Diabetes
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-issues-draft-guidance-early-clinical-studies-certain-medical-devices-improve-glycemic

 
Categories
rss rss-es rss-pt

FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination

Murilo Freitas - 15:57, 18 de mayo de 2021885

FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-advises-against-use-sars-cov-2-antibody-test-results-evaluate-immunity-or-protection

 
Categories
rss rss-es rss-pt

Dibar Nutricional S. de R.L. De C.V. Issues Voluntary Nationwide Expanded Recall of Dibar Labs Hand Sanitizer Due to the Presence of Methanol (Wood Alcohol)

Murilo Freitas - 04:00, 18 de mayo de 2021471
Morelia, Michoacán, Mexico, Dibar Nutricional S. de R.L. De C.V. (“Dibar”) is voluntarily recalling all Dibar Labs Hand Sanitizer packaged in 8oz and 16 oz bottles, respectively, to the consumer level (see Label 1 below). Dibar is also voluntarily recalling ProtectoRx Hand Sanitizer packaged in 2oz

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dibar-nutricional-s-de-rl-de-cv-issues-voluntary-nationwide-expanded-recall-dibar-labs-hand

 
PRAIS 2.0